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ABSTRACT
Purpose: The South London and Maudsley National
Health Service (NHS) Foundation Trust Biomedical
Research Centre (SLaM BRC) Case Register and its
Clinical Record Interactive Search (CRIS) application
were developed in 2008, generating a research
repository of real-time, anonymised, structured and
open-text data derived from the electronic health record
system used by SLaM, a large mental healthcare
provider in southeast London. In this paper, we update
this register’s descriptive data, and describe the
substantial expansion and extension of the data
resource since its original development.
Participants: Descriptive data were generated from
the SLaM BRC Case Register on 31 December 2014.
Currently, there are over 250 000 patient records
accessed through CRIS.
Findings to date: Since 2008, the most significant
developments in the SLaM BRC Case Register have
been the introduction of natural language processing to
extract structured data from open-text fields, linkages
to external sources of data, and the addition of a
parallel relational database (Structured Query
Language) output. Natural language processing
applications to date have brought in new and hitherto
inaccessible data on cognitive function, education,
social care receipt, smoking, diagnostic statements and
pharmacotherapy. In addition, through external data
linkages, large volumes of supplementary information
have been accessed on mortality, hospital attendances
and cancer registrations.
Future plans: Coupled with robust data security and
governance structures, electronic health records
provide potentially transformative information on
mental disorders and outcomes in routine clinical care.
The SLaM BRC Case Register continues to grow as a
Strengths and limitations of this study
▪ Because the Clinical Record Interactive Search
(CRIS) model draws directly from the electronic
health record, it provides valuable ‘real-world’ and
‘real-time’ information on routine mental healthcare,
automatically accumulating large volumes of data
without any requirement for service reconfiguration
or changes at the clinical interface.
▪ Although electronic health records-based registers
remove the requirement for specific ‘data collection’
in routine clinical care, a major challenge for
mental health data in particular is that most infor-
mation is recorded in text rather than structured
fields. Natural language processing offers import-
ant opportunities for data enhancement.
▪ External data linkages are also potentially valuable,
but dependent on the nature of the data supple-
mented—most often providing additional informa-
tion on exposures and outcomes outside mental
health domains and between care episodes rather
than on the nature of mental disorders themselves.
▪ Regardless of the volume of data available, it is
important to bear in mind their provenance (ie,
highly dependent on what information a clinical
staff member records or not); research applications
need to be tailored with this in mind.
▪ A key challenge inherent with all use of healthcare
data is data protection, and it is important to
develop anonymised data resources in a way that is
acceptable to the general public, and to the
patients whose personal and often highly sensitive
information forms the database. Such challenges
incorporate not only a case register’s data them-
selves but also procedures around data linkage
where use of identifiers is required.
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database, with approximately 20 000 new cases added each year, in
addition to extension of follow-up for existing cases. Data linkages
and natural language processing present important opportunities to
enhance this type of research resource further, achieving both
volume and depth of data. However, research projects still need to be
carefully tailored, so that they take into account the nature and
quality of the source information.
INTRODUCTION
It is nearly 30 years since the publication of Ten Horn
et al’s1 comprehensive inventory of the psychiatric case
register and its use in research. Seven years ago elec-
tronic health record (EHR)-based registers were pro-
posed as a possible ‘new generation’.2 The longitudinal
nature of case registers, their size and coverage of
defined populations make them an important research
asset, providing large numbers of participants and meas-
urement points, as well as the potential for data
linkage.3 Recent years have seen an increase in the use
of the psychiatric case register for research purposes,
including linkage across diverse health and other popu-
lation databases, including criminological information
resources.4 There are several unique applications of case
registers. Despite the methodological advantages of the
randomised controlled trial, observational data remain
fundamental to health research, and much of what we
know (or assume we know) is derived from observation
rather than experimental intervention.5 Although they
can contribute to aetiological research, case registers are
particularly suited to the investigation of the course and
outcome of a disorder, as well as allowing intervention
response to be evaluated in large, naturalistic samples
and settings. In smaller scale psychiatric case registers,
quality of data can be more regularly checked and the
number of variables collected can be higher than in a
large database. These registers can include information
on the clinical condition of the patients, on psychophar-
macological treatments and on duration of contacts.6
The combination of quality and quantity in data renders
small-scale registers of great interest for researchers and
policymakers. EHRs in mental healthcare, on the other
hand, represent data which are potentially both large
and deep—because in theory, these contain every piece
of information that has been recorded in a clinical
service about a person’s presentation, symptoms and
relevant background history, as well as interventions
received and observed outcomes.5
Through technological advances in both the daily
updating and validation of registers, large and complex
projects can be carried out. Register data are particularly
suited to supporting comprehensive longitudinal studies
of the course of illness to predict outcomes and natural-
istic response to interventions. With EHRs increasingly
complementing or replacing handwritten notes in
mental health services, large volumes of clinical informa-
tion are now already contained in an electronic format.
This removes the requirement for de novo data collec-
tion and entry which presented formidable challenges
for earlier registers, albeit processes with a higher poten-
tial for quality control. Local EHR-sourced registers are
more likely to be limited by migration between geo-
graphic catchments, but their strength lies in their
ability to cover all types of service within a given area,
thereby providing a more comprehensive picture of
mental health than is afforded by national registers.
The South London and Maudsley National Health
Service (NHS) Foundation Trust Biomedical Research
Centre (SLaM BRC) Case Register was set up in 2008
as a novel data resource derived directly from the
routine EHRs of a large mental healthcare provider,
and its initial development was outlined in 2009.7 At
the time of analysis for that paper (October 2008), the
database contained 123 000 cases and information
available through the Clinical Record Interactive
Search (CRIS) application was primarily restricted to
that imposed by the format of the source EHR fields.
Since then, the SLaM BRC Case Register has expanded
substantially, not only in case numbers (now over
250 000) but also, most importantly, in the scale and
depth of derived and externally linked information
available. The objective of this paper is to update the
description of this case register and, particularly, to
outline technical developments which have enhanced
the depth of information available, and which we
believe have potential generalisability to other compar-
able clinical data resources.
COHORT DESCRIPTION
The SLaM BRC Case Register and CRIS application
Initial development of the SLaM BRC Case Register has
been previously described in detail, as has SLaM as a
provider (and see also http://www.slam.nhs.uk).7 In
summary, the data are sourced from EHRs used by
SLaM, which provides comprehensive mental health ser-
vices to a geographic catchment of over 1.2 million resi-
dents in four south London boroughs—Croydon,
Lambeth, Lewisham and Southwark—as well as some
regional/national specialist services. SLaM catchment
service provision is currently structured within the fol-
lowing specialty groupings: Addictions; Behavioural and
Developmental Psychiatry; Child and Adolescent Mental
Health Services; Mental Health of Older Adults and
Dementia; Mood, Anxiety and Personality; Psychological
Medicine; Psychosis. These are aligned with academic
groupings at King’s College London, reflecting the uni-
versity–health service partnership enshrined within
King’s Health Partners Academic Health Sciences
Centre (KHP AHSC; http://www.kingshealthpartners.
org; also incorporating two major acute care providers).
The groupings also encompass services delivered to all
age groups, standard specialties such as Addictions,
Eating Disorders and Learning Disabilities, as well as
provision within Forensic and General Hospital Liaison
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settings. In addition, wider national provision by SLaM
at the time of writing includes the following services:
adult attention deficit hyperactivity disorder, adult per-
sonality disorder, affective disorders, anxiety disorders
(residential), autism assessment and behavioural genet-
ics, brain injury (outpatient and inpatient), anxiety dis-
orders and trauma, chronic fatigue, eating disorders
(day care, outpatients, inpatients), female hormone
clinic, psychosis (inpatient, outpatient and specialist
rehabilitation), mother and baby unit, autism, practi-
tioner health, psychological interventions, psychosexual
disorders, self-harm (outpatients) and traumatic stress.
Finally, some SLaM services provide to a wider geo-
graphic catchment (eg, Addiction services to Bexley and
Greenwich boroughs) and others are catchment inde-
pendent (eg, General Hospital Liaison services are pro-
vided to the four Acute Trusts within the catchment
regardless of individual patients’ areas of residence).
Clinical records have been fully electronic (ie, paper-
less) across all SLaM services since April 2006, using the
bespoke Patient Journey System (PJS) which incorpo-
rated legacy data from earlier service-specific EHRs. The
CRIS application was developed in 2007–2008 and con-
sists of a series of data-processing pipelines which both
structure and de-identify PJS fields, rendering effectively
anonymised data from the full clinical record available
at the researcher interface, with search and database
assembly functionality facilitated by a front end designed
for non-technical use. The anonymisation process and
its effectiveness, including the de-identification of open-
text fields and the generation of a pseudonymised iden-
tifier (CRIS ID), have been described in detail.8 The
wider patient-led oversight and security model have also
been previously described and have not changed signifi-
cantly since the SLaM BRC Case Register was set up.7 8
Ethical approval as an anonymised database for second-
ary analysis was originally granted in 2008, and renewed
for a further 5 years in 2013 (Oxford C Research Ethics
Committee, reference 08/H0606/71+5). In terms of
cohort coverage, all SLaM care is represented on CRIS.
An opt-out model is in place for service users, and is
advertised in all publicity material and initiatives; to
date, only three people have requested this.
The SLaM BRC Case Register conforms to the WHO’s
formal description of a psychiatric case register—a
‘patient-centred longitudinal record of contacts with
a defined set of psychiatric services originating from a
defined population’,9 although its dynamic nature,
updating against source files every 24 h, renders it dis-
tinct in some respects. The inclusion of both structured
and unstructured (open-text) data in anonymised form,
also variously distinguish the SLaM BRC Case Register
from other local, regional and national case registries,
including those extracted from EHRs such as the
disease registries maintained by the US Veteran’s
Administration.10 11 Routinely collected data resources
such as the Mental Health Minimum Dataset and
Hospital Episode Statistics (HES) for England and Wales
overlap with SLaM Case Register data but are limited to
prespecified structured fields.
Early experience with CRIS and its influence on
subsequent design
Developments in the technical architecture underlying
CRIS are summarised in the online supplementary
appendix and the current model is displayed in figure 1.
Studies published to date using CRIS-derived data have
generally fallen into two groups. The first have used a
combination of open-text and structured data, with
open-text data identified using search terms and then
manually coded into numeric form for the purpose of
analysis. Because of this, sample sizes have been limited
to no more than several hundred. However, productive
examples include one of the largest case series
assembled of people with neuroleptic malignant syn-
drome, in order to evaluate the range of diagnostic cri-
teria,12 and associations with antipsychotic exposure,13 as
well as a study of factors associated with khat use in a
comprehensive sample of Somali mental health service
users.14 The second group of studies have used only
structured data or have made very limited use of open-
text data. These have typically analysed sample sizes of
several thousand or more. Examples include studies of
residential mobility and of homelessness among inpati-
ents on mental health wards, and a series of investiga-
tions of mortality associated with mental disorder,
described later.15 16
Important experiential learning occurred during the
initial stages of CRIS use. First, we found that it was
sometimes desirable to select and combine data from
records in ways that were unsupported by the original
CRIS interface (eg, because of complex temporal rela-
tionships required between fields). Second, it became
clear that while being able to identify and retrieve open-
text records according to the presence of prespecified
search terms did achieve helpful economy of effort, it
did not remove the work needed to generate quantita-
tive data from open text. Indeed, for those projects
dependent on the use of open text, the manual coding
process placed important limitations on sample size and
study duration. Finally, researchers began to develop
ideas that required data in addition to those stored in
the source EHR, such as data from primary care, acute
care and outcomes such as mortality. In the succeeding
sections, we set out how the SLaM BRC Case Register
has evolved to respond to these challenges.
Handling open text
As outlined above, a priority for development has been
to develop more efficient ways of using open-text data in
the SLaM BRC Case Register. Early case register data col-
lection included manually reading the de-identified text
fields returned by CRIS, such as routine case notes, cor-
respondence and medication notes. For example, one of
the recent publications involved manually reading of
2860 records on CRIS of patients receiving
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acetylcholinesterase inhibitors in order to record their
Mini-Mental State Examination (MMSE) scores and
respective dates, and other medication prescribed.17
Through this process over 11 000 MMSE scores were
ascertained; however, there were significant demands in
terms of time and resources and the exercise was only
possible as the focus of a PhD studentship. Beyond the
efficiencies in manual coding gained by extracting only
those records required for coding, through keyword
searches and postsearch processing, further gains may
be made by displaying text fields in ways that make text
of interest easier to see, and by displaying data that are
required to be reviewed together in close proximity, and
away from other data. For example, in studies of home-
lessness and residential mobility among inpatients, 4485
admissions were selected according to defined criteria,
and free-text records corresponding to these admissions
were selected if they contained the terms ‘homeless’,
‘NFA’ or ‘no fixed abode’.15 16 The aim was to check
structured data on homelessness against free-text data,
and if necessary, to supplement the former. SAS was
used to insert ‘tags’ that change font colour (red) and
weight (bold) for the target words when the data are dis-
played in Excel, allowing around 2000 free-text progress
notes to be coded as homeless/not homeless in less
than a day. A SAS Enterprise Guide project developed in
collaboration with Amadeus Software Ltd allows CRIS
users to do this via a graphical user interface.
A more ambitious approach has been followed for an
ongoing project to capture incident cases of psychosis,
supported by another Enterprise Guide project devel-
oped in collaboration with Amadeus Software Ltd. First,
a structured query language (SQL) query retrieves a
selection of data for individuals not already present on a
cumulative database of first-episode psychotic patients
and not already diagnosed as having a psychotic dis-
order, and whose recent free-text entries contain particu-
lar words of interest such as ‘delusion’ or ‘hallucination’.
Second, these data are imported into SAS and then auto-
matically outputted in a format suitable for manual
coding. This involves splitting data into a multiworksheet
Excel workbook, such that each worksheet (tab) con-
tains only data relating to a single person (in the case of
our proposed project, each worksheet would similarly
pertain to a single episode of care). Targeted words are
displayed in colour and in bold.
In contrast to the facilitated, but still manual
approaches described above, natural language process-
ing (NLP) techniques have been evaluated and applied
for extracting knowledge from unstructured text data.
For our purposes, the key NLP technique has been
information extraction (IE) where unstructured text is
converted into structured tables.18 Such methods
promise massive reductions in the time resource
required by researchers to unlock information held in
clinical notes that in turn may be connected to other
parts of the structured record. It was therefore decided,
early in the postdevelopment phase, to implement a
text-mining capability in CRIS. This was to be generic, in
that information to be extracted could not necessarily
be foreseen in advance of the design of individual
research studies. General Architecture for Text
Engineering (GATE) was chosen as the core NLP infra-
structure for CRIS.19 20 GATE is a widely used suite of
open source software for text engineering that includes
a workbench for developing applications, tools for dis-
tributing those applications on different computer hard-
ware architectures, a quality assurance suite and facilities
Figure 1 Diagram/map of CRIS
technical architecture including
natural language processing and
data linkage. CRIS, Clinical
Record Interactive Search; GATE,
General Architecture for Text
Engineering; SLaM, South
London and Maudsley.
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for manual preparation of example data.19–21 GATE’s
origins are in clinical IE and it has been widely applied
in this context.22 23 GATE includes a flexible architec-
ture for IE and text mining, a large set of pluggable text
processing components, and graphical tools for organis-
ing those components into new applications. The GATE
suite also includes tools for text-mining workflow, distrib-
uted processing and visualisation. A variety of text pro-
cessing tools and document formats may be plugged
into this architecture, with individual tools being
chained together into processing ‘pipelines’, and docu-
ments processed in series through these pipelines.
Two distinct shallow language processing methodolo-
gies have been adopted for CRIS development, in collab-
oration with University of Sheffield Department of
Computer Science. The first may be described as rule-
based pattern matching of key concepts. Sentences are
first processed to find and create annotations based on
simple surface linguistic information (such as words,
sentences, etc). This step is then followed by the process
of finding concept-specific keywords, which are used to
recognise likely sentences of importance to the IE task.
For example, in an application to determine the
smoking status of a patient implied by texts, such a dic-
tionary, might list the terms of common tobacco pro-
ducts and activities—‘cigarette’, ‘smoker’, etc. Finally, a
set of patterns specific to the text-mining task are run
over the previously generated annotations in order to
create a final annotation containing all of the informa-
tion required in a readily extractable format. The chal-
lenge of the pattern matching approach is that it is
knowledge intensive. A successful series of patterns need
to be developed in relation to a specific IE task (eg, to
extract medications, educational level or particular test
results). They have to be built manually by GATE users
with language engineering skills, using definitions
agreed with clinicians and epidemiologists. A sample of
the output from an initial prototype application is then
corrected by a clinician or epidemiologist, which in turn
is used to stimulate discussion about requirements and
to provide a basis for multiple iterations of development
until performance requirements are met. An advantage
of this IE approach is that it also allows researchers to
combine information available from open text and struc-
tured fields available in CRIS, through SQL, thus com-
bining multiple sources of information. At the
postprocessing stage, we can further apply specific filter-
ing criteria to data extraction, such as frequency and
length of prescribing and number of concomitant
drugs, thus identifying more complex patterns in the
text, such as antipsychotic medication profiles (ie, anti-
psychotic polypharmacy).24
Because of the lengthy development cycles of building
shallow parsing algorithms, a second IE methodology
has also been evaluated. Here, support vector machines
(SVMs) are used to rapidly achieve respectable results
for certain types of IE problem. A SVM is a machine-
learning technique where the intention is to represent
instances of text as vectors in high dimensional space.
With a training set of instances labelled as indicative of a
desired class, the SVM implementation in GATE gener-
ates a hyperplane which can in turn be used to classify
unseen instances pertaining to the described class in the
training set. In practice, this primarily uses a technique
known as ‘bag of words’, where the occurrence of single
words within a sentence is the principal currency used
to distinguish the various classes. The first part of the
model construction requires an expert (eg, clinician) to
review a set of documents and label sentences which are
relevant to the concept in question, in much the same
way that they might signal to a language engineer the
relevance of a given sentence for a pattern-based
approach. The combination of labelled and unlabelled
sentences forms the training data, from which the SVM
learns the classification function. This model is then
applied to unseen data, and the model quality assessed
by human review. If required, further training data can
be supplied, which may involve an active
learning-inspired approach. A limitation with SVMs
applied in CRIS has been that they have limited suitabil-
ity for complex data extraction problems; however, in
scenarios where the assertion to be extracted is simple
and tend to be restricted to a concise set of clinical lan-
guage, performance has been found to be very good
and IE applications with immediate utility can be rapidly
developed.25 The TextHunter program was designed
specifically to aid the process of clinical text annotation
in CRIS, providing an easy-to-use interface for annota-
tors with a focus on the sentence containing the word(s)
of interest and immediately proximal text and function-
ality for rapid coding into discrete groups, typically com-
prising the following: (1) positive (ie, implying that the
construct is present); (2) negative (ie, a statement indi-
cating that the construct is absent); and (3) irrelevant
text.26 Additional TextHunter functionality includes plat-
forms for interannotator agreement testing, and the cre-
ation of gold standard and test annotation sets.
Whether rules-based or machine-learning approaches
are used, separate training and test data sets are con-
structed. Standard metrics for evaluating IE application
performance in the test data sets, at the level of the indi-
vidual text annotation, comprise precision (equivalent
to positive predictive value; the proportion of IE applica-
tion ‘hits’ which are found to identify the genuine con-
struct) and recall (equivalent to sensitivity; the
proportions of instances of the genuine construct which
are identified by the application). Employing text
mining within the CRIS data set has involved a trade-off
between the two. However, the longitudinal nature of
EHR data means that there are generally multiple
opportunities for an NLP application to capture a piece
of information; therefore, suboptimal recall can be com-
pensated for and the focus has been on maximising pre-
cision. For the purpose of precision and recall testing,
there are two reportable outcomes. The first is ‘annota-
tion level’, which is carried out across randomly selected
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documents and is an indicator of the base level of per-
formance of the application. This figure is useful for
developmental purposes, or, in the case of simple con-
cepts that do not require postprocessing, for estimating
the final performance of the algorithm. The second
type of precision and recall are ‘currency level’, measur-
ing performance after postprocessing.
The SLaM Clinical Data Linkage Service
SLaM comprises one part of the KHP AHSC (established
with King’s College London, Guy’s and St Thomas’ and
King’s College Hospitals NHS Foundation Trusts) and
received National Institute of Health Research (NIHR)
funding to set up a service to meet the growing demand
from SLaM and KHP researchers whose projects require
linked data extracts. SLaM consequently established the
Clinical Data Linkage Service (CDLS) as a trusted third
party safe haven set up to enable safe and secure data
processing services (linkage, and/or storage, and/or
extraction) on distinct data sets for secondary research
use. The two main methods of linkage have involved
either (1) CDLS performing a secure linkage using
deterministic or probabilistic matching if/as required or
(2) CDLS supporting another trusted third party service
to perform the linkage outside of the SLaM electronic
firewall followed by CDLS receiving the linked data after-
wards (eg, CRIS-HES linkage). Linked data are stored by
CDLS in accordance with the SLaM ICT Security Policy
and a set of standards contained in a CDLS
Memorandum of Understanding completed by the data
controllers providing data to individual projects, prior to
undertaking any data processing for the project. Linked
data are stored on a CDLS server within the SLaM fire-
wall. To date, linkages have been successfully carried out
between CRIS and a number of databases, described
below.
Primary care (Lambeth DataNet)
Lambeth DataNet (LDN) has been used for several
research studies.27 28 Using the services of a contracted
partner, Quality Medical Solutions (QMS) until April
2014, data are extracted and pseudonymised from the
general practitioner (GP) practices in question. In terms
of the mechanism of linkage, QMS scramble the patient
identifiable information (NHS number) within the com-
plete LDN data set and send the algorithm to the CDLS
using an official encrypted NHS data transfer method to
allow linked data files to be generated within CDLS. All
identifying data other than CRIS and LDN pseudonyms
are then removed. On final approval, SLaM BRC
researchers will submit their data extract request to
CDLS, either using CRIS to identify a discrete list of
client pseudonyms for their project cohort to be linked
with CRIS and LDN data (this pseudonym is not
returned to the researcher), or submitting a detailed
description of the cohort under investigation for CDLS
to assemble the corresponding linked data. Once the
linkage is complete, the LDN ID pseudonym is
destroyed and an anonym (project-specific ID) is used
thus creating a project-specific, fully anonymised data set
for analysis. LDN currently extracts data from all GP
practices in Lambeth—that is, around a quarter of the
geographic catchment served by SLaM.
Department for Education National Pupil Database
The Education (Individual Pupil Information;
Prescribed Persons; England) Regulations 2009 as
amended by The Education (Individual Pupil
Information; Prescribed Persons; England; Amendment)
Regulations 2013 enable the Department for Education
(DfE) to share individual pupil information from the
National Pupil Database (NPD) with named bodies and
persons who, for the purpose of promoting the educa-
tion or well-being of children in England, are conduct-
ing research or analysis, producing statistics, or
providing information, advice or guidance. Access is
subject to requesters complying with terms and condi-
tions imposed under contractual arrangements and a
rigorous approvals process. The DfE Data Management
Advisory Panel approved the DfE Data and Statistics div-
ision linkage service to undertake the linking of IDs
between CRIS and the NPD. In terms of the data
linkage mechanism, SLaM CDLS will first identify all
children under 17 on the CRIS database, comprising
approximately 35 000 cases who have attended SLaM
Children and Adolescent Mental Health Services
between 1 January 2008 and 31 December 2013.
Identifiers will then be sent via secure file transfer to the
DfE Data and Statistics Department who will match
these against the NPD identifiers cohort (approximately
15 million records), generating a pupil-specific, non-
identifiable NPD ID variable across the whole data set,
and adding the CRIS ID to this table for cases only, strip-
ping the resultant table of all identifiers other than the
anonymised NPD ID and the pseudonymised CRIS ID,
and transferring the data set back to SLaM CDLS using
secure file transfer. Researchers on approved projects
will compile clinical data from CRIS for approved ana-
lyses and send to CDLS for linking. CDLS will then fully
anonymise resultant tables by replacing the CRIS ID for
cases throughout with a project-specific CDLS ID, and
the link between the CRIS ID and CDLS ID will be per-
manently destroyed prior to sending linked tables to
researchers for analysis.
Hospital Episode Statistics
HES data are compiled from all NHS Trusts in England
(both acute and mental health services), including statis-
tical abstracts of records of all inpatient episodes, as well
as outpatient and emergency care. For this linkage,
CRIS identifiers are compiled by CDLS, and transferred
to the Health and Social Care Information Centre
(HSCIC) using an NHS-approved secure file transfer
protocol. HSCIC then adds the CRIS ID to all HES
records that match CRIS records and extracts all other
HES records for patients within the four catchment
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boroughs served by SLaM (the control group). HSCIC
destroys patient identifiers leaving only the CRIS ID and
HES extract ID. As with other linked data sets, the
CRIS-HES data are transferred back to CDLS to be held
and provided to researchers in a fully anonymised
format.
Mortality
Office for National Statistics (ONS) mortality data are
additionally requested via the HSCIC. CDLS send identi-
fiers (CRIS ID, first name, last name, date of birth,
gender, postcode and NHS number) to HSCIC, who
return ONS mortality data to CDLS via the same secure
file transfer protocol as that used for the HES linkage.
While ONS mortality data include details of information
recorded on the death certificate, date of death is avail-
able on a wider CRIS sample through data held by
SLaM, in common with most mental health NHS Trusts
through standard linkage of all NHS numbers to the
national spine.
Cancer
In an initial piece of work, a data linkage was set up
between CRIS and Thames Cancer Register by the UK
Government Department of Health Research Capability
Programme, findings from which have been previously
reported and which generated an irreversibly anon-
ymised linked data set.29 This data resource is currently
being expanded to bring together updated local data
from the National Cancer Registration Service (NCRS)
held by Public Health England’s London Knowledge
and Intelligence Team, linking this with CRIS and
incorporating additional HES and mortality data pro-
vided by HSCIC and ONS.
Procedures and resources
Results from all these linkages are stored within the
CDLS safe haven, and CDLS plays a key role in wider
governance, supplementing the role of CRIS-specific
oversight and data security previously described.7 8
While set up to support research at the SLaM BRC, as
an independent trusted third party service CDLS sits
outside the BRC and is managed by a dedicated team
within the SLaM Information and Communications
Technology department, reporting directly to the SLaM
Director of ICT Strategy and ultimately accountable to
the SLaM Trust Board. Important features of CDLS
work are the secure handling and storage of identifier
fields required for data linkage. Section 251 (s.251) of
the NHS Act 2006 allows the common law duty of confi-
dentiality to be set aside in specific circumstances where
anonymised information is not sufficient and where
patient consent is not practicable. S.251 approval has
been granted to SLaM for all the above linkages, which
allow data to be available in an identifiable format to a
small number of data processing staff in accordance with
data sharing contracts. Activity for projects using linked
data sets held by CDLS is audited by the CDLS Safe
Haven Officer, helping to ensure that the user’s project
requirements (eg, clinical research, surveillance, service
improvement or audit) are met, and projects progress
within the agreed policy and practice framework. The
CDLS communications plan has a patient-facing aspect
in raising awareness of the projects facilitated by the
CDLS. Service user involvement is ensured in the
decision-making process of approving projects working
with linked data held by CDLS, and the patient-chaired
CRIS Oversight Committee reviews and approves all pro-
jects using CRIS-linked data. Separate committees with
the same terms of reference have been set up to provide
governance for the LDN and NPD linkages, in order to
accommodate representation from respective agencies
providing these data.
Four distinct services are thus offered by the CDLS.
First, CDLS provides advice on permissions, approvals
and contracts. These include consideration of academic,
technical, legal and ethical requirements. The SLaM
‘Caldicott Guardian’ is responsible for any use of patient
identifiable information and their approval is also a pre-
requisite. Second, CDLS facilitates data linkages either
within the CDLS safe haven or via a third party, coordin-
ating the secure transfer of data. Third, CDLS is respon-
sible for the secure storage of linked data in accordance
with predefined information governance and security
standards. Fourth, CDLS as the custodian for the linked
data prepares and extracts bespoke and prespecified
databases for approved CRIS projects and provides these
to researchers. Therefore, there is no direct access by
researchers to the full linked data files, enhancing data
protection and confidentiality.
Cohort characteristics
Initial descriptive data were assembled on the catchment
area for SLaM (Croydon, Lambeth, Lewisham and
Southwark) using publicly available sociodemographic
information from ONS census data.30 Analyses of CRIS
data used 31 December 2014 as a census date for
descriptive statistics including sociodemographic and
diagnostic profiles. ‘Active’ patients on this date were
defined as those who had been referred to and accepted
by SLaM and had not been discharged by 31 December
2014. ‘Inactive’ patients had a recorded activity date on
or before 31 December 2014 and excluded referrals
categorised as ‘rejected’ or ‘waiting’. On 31 December
2014, 223 224 patient records were available on CRIS, of
which 31 961 described ‘active’ patients and 191 263
‘inactive’. The remaining 21 882 records described refer-
rals, which were either solely characterised as ‘rejected’
or ‘waiting’, and in which no team episode (for outpati-
ents) or ward stay (for inpatients) was indicated.
Descriptive data were further provided for key linked
data sets at that time. In this respect, the most recent
mortality date recorded in the linked ONS mortality
data set was 16 December 2013; cancer registry data
were linked up to 31 December 2008; HES data were
available to 31 March 2013. For analyses of linked HES
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data, contacts with mental health services were
excluded.
Descriptive data from the UK Census for the catch-
ment populations served by SLaM are summarised in
table 1 and contextualised with the same information for
London as a whole and for England. There are slight dif-
ferences in population structure between the four bor-
oughs served, with Croydon having higher proportions
of young children and older residents compared with
London and the other three boroughs. Highest propor-
tions in the young adult (20–39 year) age range were
living in Lambeth and Southwark. As a whole, the SLaM
catchment has a slightly higher predominance of
working adults in the 20–59-year range compared with
London, and shares with London lower proportions in
older age ranges compared with England. The SLaM
catchment has substantially higher proportions of resi-
dents from minority ethnic groups and/or born outside
UK compared with England, whereas compared with
London as a whole, there are higher proportions from
black minority groups and lower proportions from Asian
groups. In common with London as a whole, propor-
tions are higher in both highest and lowest socio-
economic groups compared with England; proportions
in unemployment are higher, but so are proportions
with higher levels of education. Of the catchment bor-
oughs, Lambeth, Southwark and Lewisham have higher
levels of both in-migration and out-migration compared
with Croydon. Based on the ratios between summed
borough statistics and those for the catchment overall,
76.9% of inflow migration and 78.5% of outflow migra-
tion was from/to areas outside the catchment, rather
than between catchment boroughs.
Geographic characteristics are summarised in figures
2–4. Figure 2A visually contextualises deprivation levels
in SLaM compared with other areas of London, and
figure 2B summarises the most recently recorded resi-
dence of active SLaM patients. In the latter, most active
SLaM patients were identified as residing within its geo-
graphic catchment, although appreciable numbers were
drawn from a wider geography. Within the SLaM catch-
ment, higher numbers of active patients were generally
found in areas of higher deprivation, although several
anomalous areas can be seen—for example, those with
high deprivation and relatively low numbers of active
patients (figure 3A, B). Figure 4 illustrates the most
recent recorded residence of non-active patients in
London (figure 4A) and specifically in SLaM’s catch-
ment (figure 4B). Outside SLaM’s catchment, relatively
high numbers of inactive patients were recorded as res-
iding in neighbouring local authorities in South East
London including Bexley, Greenwich and Bromley.
Descriptive data are summarised in table 2 for all
people who were represented on the SLaM BRC Case
Register on 31 December 2014. Higher proportions of
active patients were 80 years and older and in the 40–59
group compared with proportions in the four catch-
ments. Compared with the catchment area
characteristics described in table 1, active SLaM patients
had a slightly higher male predominance, and there
were higher proportions self-assigning as white, mixed
or other ethnicity. Around 70% were single.
Employment status data were available on less than 25%
of the active sample, but of this group around 66% were
unemployed. Of active SLaM patients on the census
date, 6574 (20.9%) were either residing in boroughs
outside London or living in London but outside SLaM’s
four catchment boroughs. Of these, 3385 (51.5%) were
in contact with SLaM services that provided for other
boroughs, 1941 (29.5%) were using one or more of
SLaM’s national services, 341 (5.2%) were in contact
with General Hospital Liaison services covering one of
the four Acute Trusts within the SLaM catchment, and
907 (13.8%) were previous catchment residents cur-
rently living outside the catchment (193 of whose
addresses were recorded as temporary).
On the 31 December 2014 census date, there were
nearly 32 000 active cases receiving care from SLaM ser-
vices, with the largest numbers receiving care from
Psychosis or Child and Adolescent Mental Health
Services (table 3). A further 190 000 plus patients on
the SLaM BRC Case Register were inactive to SLaM,
nearly one-third of whom received care from
Psychological Medicine services (which includes
General Hospital Liaison services). Table 4 provides an
additional description of overlap between services for
active and inactive patients, with over 1000 active
patients in contact with two or more specialties concur-
rently and over 15 000 inactive patients having received
care from two or more specialties. Ever-recorded
primary diagnoses are summarised in table 5. Of active
patients, the most common mental disorder diagnoses
ever recorded were schizophrenia (21.2%) and mood
(19.0%) disorders, followed by organic (11.0%), sub-
stance use (11.7%) and neurotic (13.0%) disorders, and
disorders of childhood and adolescence (11.3%). Sizes
of data linkage samples are described in tables 6–8.
Nearly 85% of CRIS patients had records in HES
(excluding mental health service data) and nearly 2%
of CRIS patients had data linked to those from the
cancer registry within the years of data availability (table
6). Distributions of underlying cause of death are sum-
marised in table 9 for the linked sample with this infor-
mation, and primary cancer diagnoses are similarly
described in table 10.
Performance of NLP applications
Performances of IE applications to date are sum-
marised for CRIS as a whole, supplementary to more
detailed publications on some of these.31 32 33 34 The
first NLP IE application to be developed was for the
MMSE, a commonly used 0–30-point assessment of
global cognitive function. The objective of the applica-
tion was to ascertain both the numerator and denomin-
ator scores (because denominator scores of less than 30
are used where some items cannot be attempted
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Table 1 Descriptive statistics, derived from the 2011 UK Census, for the four London boroughs served by SLaM, compared
with statistics for London and England as a whole
SLaM catchment Comparison statistics
Lambeth Croydon Lewisham Southwark Combined London England
Total population* 310 200 368 900 281 600 293 500 1 254 200 8 308 400 53 493 700
Age (%)
<20 21.7 26.9 25.4 23.0 24.4 24.5 24.0
20–39 44.2 29.3 36.3 41.7 37.5 35.8 27.0
40–59 23.4 26.9 25.3 24.4 25.1 24.5 26.7
60–79 8.6 13.5 10.3 8.8 10.4 12.1 17.7
≥80 2.1 3.4 2.7 2.1 2.6 3.1 4.6
Gender (%)
Male 49.8 48.5 48.9 49.5 49.1 49.3 49.2
Female 50.2 51.5 51.1 50.5 50.9 50.7 50.8
Education† (%)
No qualifications 14.2 17.6 17.7 16.3 16.5 17.6 22.5
Highest level of qualification;
level 1 qualifications
8.5 13.8 11.1 9.4 10.9 10.7 13.3
Highest level of qualification;
level 2 qualifications
9.8 15.2 12.5 10.2 12.1 11.8 15.2
Highest level of qualification;
apprenticeship
1.1 2.1 1.4 1.2 1.5 1.6 3.5
Highest level of qualification;
level 3 qualifications
9.7 11.4 10.8 10.5 10.6 10.5 12.4
Highest level of qualification;
level 4 qualifications and above
46.6 31.8 38 43.1 39.5 37.7 27.4
Highest level of qualification;
other qualifications
10.1 8.1 8.5 9.3 9.0 10.1 5.7
Self-assigned ethnicity (%)
White 57.1 55.2 53.5 54.3 55.1 59.8 85.5
Mixed 7.6 6.4 7.4 6.2 6.9 5.1 2.2
Asian or Asian British 6.8 16.4 9.3 9.5 10.8 18.4 7.7
Black or Black British 25.9 20.2 27.2 26.8 24.7 13.3 3.4
Other 2.6 1.8 2.6 3.2 2.5 3.4 1.2
Socioeconomic classification (%)‡
Higher managerial, administrative
and professional occupations
16.2 14.1 13.1 15.8 14.8 15.8 13.8
Lower managerial, administrative
and professional occupations
27.3 24.8 25.7 24.8 25.6 24.7 22.8
Intermediate occupations 10.6 13.7 12.1 10.3 11.8 10.9 10.5
Small employers and own
account workers
9.7 12.9 10.9 8.8 10.7 12.9 12.8
Lower supervisory and technical
occupations
5.9 6.7 6.8 6.6 6.5 6.5 8.8
Semiroutine occupations 10.3 12 12.6 12 11.7 10.9 13
Routine occupations 9.7 8.3 8.7 9.9 9.1 8.8 12.1
Never worked and long-term
unemployed
6.9 5.3 6.4 7 6.3 6.5 4.2
Full-time students 3.4 2.2 3.7 4.8 3.4 3 2
Percentage of people born in UK 61.1 70.4 66.4 63.2 65.5 85.8 94.1
Estimated migration (thousands per year) for the 1 year period ending June 2014§
Inflow 29.07 19.19 21.2 25.25 72.81 196.6 526
Outflow 31.78 19.81 22.36 27.53 79.71 251.6 314
Balance −2.71 −0.62 −1.16 −2.28 −6.90 −55 +212
*Resident population estimates by broad age band, mid-2013, using ONS 2011 census.
†All usual residents aged over 16 on the census date 27 March 2011.
‡Based on HRP: an individual person within a household to act as a reference point and charactering whole household according to
characteristics of the chosen reference person.
§Data source: http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-326817 accessed on the 5 November
2015. SLaM catchment and London statistics calculated for the 1 year period ending June 2013 (and the overall catchment statistic does not
include within-catchment migration); England figures represent rolling annual data for year ending June 2014.
HRP, household reference person; ONS, Office for National Statistics; SLaM, South London and Maudsley.
Perera G, et al. BMJ Open 2016;6:e008721. doi:10.1136/bmjopen-2015-008721 9
Open Access
 o
n
 June 23, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2015-008721 on 1 March 2016. Downloaded from 
because of, eg, sensory impairment), as well as the date
implied for the assessment (because clinical text fields
commonly refer to previous as well as current scores).
Further rules for application postprocessing were that
only MMSE scores with denominators over 25 were
included (because scores below that level imply sub-
stantial missing data and a scale that was probably
incompletely administered), and scores were excluded
if two different numerators were assigned to the same
date.34 The application for educational attainment
sought to ascertain the numeric value associated with
text commenting on school leaving age, whether the
age itself or the year, and the application for ‘living
alone’ simply sought to identify that phrase or
equivalents applied to the patient. In developing the
smoking application, authors extracted information
from open-text fields, classifying patients as either ‘cur-
rently smoking’, ‘past smoker’ or ‘has never smoked’,
with smoking of substances other than tobacco (eg,
marijuana/cannabis and cocaine) specifically
excluded.31 The methodology used an iterative process
of manual ‘gold standard’ annotation of free-text docu-
ments, followed by comparison with the results gener-
ated by the application at each development stage, with
analysis of this comparison feeding further develop-
ment of the rules. The application for ‘diagnosis’
sought simply to extract any text strings associated with
a diagnosis statement in order to supplement the
Figure 2 Maps contextualising deprivation levels in the South London and Maudsley (SLaM) catchment compared with London
as a whole, and illustrating the distribution of recorded residences for active patients (on 31 December 2014) within London.
Figure 3 (A, B) Maps showing distribution of deprivation levels in the four catchment boroughs served by South London and
Maudsley (SLaM), the key hospital sites and the number of active patients (on 31 December 2014) across the same geography.
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existing structured (International Classification of
Diseases (ICD)-10) fields. Its performance was evalu-
ated formally in a random sample of 75 documents for
‘vascular dementia’,33 but is recommended for individ-
ual further evaluation in other conditions. The applica-
tion for ascertaining pharmacotherapy was developed
using a gazetteer of generic and commercial names for
all medications in UK use in order to ascertain
instances where the patient was reported as receiving
these, with supplementary rules for ascertaining
recorded dose, frequency/timing and starting/stopping
statements. Its precision was first tested for clozapine
receipt against a manual search of 279 documents, and
recall was ascertained on a random set of 200 docu-
ments containing the word clozapine and scrutinised to
ascertain an actual prescription.32 Finally, the validity of
this application was recently further evaluated for six
antipsychotic agents (amisulpiride, flupentixol, halo-
peridol, olanzapine, risperidone, zuclopenthixol) on
instance level (ie, specific mentions in the text at indi-
vidual points in time). To estimate precision and recall,
the authors examined a subset of 20 patients for each
medication, totalling 120 patients (the instances of anti-
psychotic prescribing varied from 328 to 1150 instances
by antipsychotic agent) by running the NLP application
over the set of unseen documents and comparing the
results to the manual coding of the same data set.24 For
all evaluations, an F-statistic was additionally calculated,
representing the harmonic mean of precision and
recall, and defined as: F=2×(precision×recall/(preci-
sion+recall)). As with the diagnosis application, further
bespoke validation of the pharmacotherapy application
is recommended for new medications or classes.
Performance data are summarised for NLP IE applica-
tions in table 11, and table 12 describes the resulting
additional structured data points generated across CRIS
using these applications.
Findings to DATE
The SLaM BRC Case Register has been used for a wide
range of research projects to date, as well as for key
service evaluation and audit projects, and over 50 publi-
cations have arisen. Large-scale outcome studies sup-
ported by CRIS data have included those of residential
mobility and of homelessness among inpatients on
mental health wards.15 16 Evaluations of service interven-
tions and other quality markers were also studied,35 36
and investigations are increasingly focusing on early
symptoms and treatment pathways in psychosis.37 38
Keyword search functionality recently supported a large
historic cohort study of service use and abuse experi-
ences of trafficked people in contact with secondary
mental health services.39
A particularly prominent theme has been the investi-
gation of mortality and physical health outcomes in
people with mental disorders. Initial reports highlighted
the raised mortality and lower life expectancy of people
in the most common disorder groups.40–43 More studies
were carried out to attempt to profile those most at risk,
which have indicated that disability and environmental
circumstances appear to be more important than symp-
toms.44 45 This was supported by a study showing that, in
those who received specific structured risk assessments,
clinician-perceived risk of self-neglect was a strong and
independent predictor of mortality, whereas clinician-
perceived risks of suicide and/or violence were not pre-
dictive.46 In terms of mortality predictors in specific
patient groups, the impact of psychiatric comorbidity
and psychological health on all-cause and cause-specific
mortality in opioid use disorder has been evaluated,
highlighting the importance of personality disorder and
comorbid alcohol use disorder.43 Similarly, the import-
ance of alcohol and drug use, physical illness, and func-
tional impairment as predictors of mortality in
individuals with personality disorder has been
Figure 4 Maps illustrating the distribution of recorded residences for inactive patients (on 31 December 2014) within London
and SLaM catchment area. LSOA, lower super output area; SLaM, South London and Maudsley.
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Table 2 Characteristics of patients represented on the South London and Maudsley National Health Service (NHS)
Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register records (census date: 31 December 2014)
Active patients (%) Inactive patients* (%)
Characteristic N=31 961 N=191 263
Current age (years)
<20 6265 (19.6) 23 740 (12.4)
20–39 9464 (29.6) 65 493 (34.2)
40–59 10 101 (31.6) 59 336 (31.0)
60–79 4017 (12.6) 23 924 (12.5)
≥80 2114 (6.6) 18 770 (9.8)
Year of birth
On or after 1994 6785 (21.2) 27 214 (14.2)
1993–1973 10 032 (31.4) 68 722 (35.9)
1973–1954 9337 (29.2) 53 317 (27.9)
1953–1934 3913 (12.2) 22 065 (11.5)
On or after 1933 1894 (5.9) 19 945 (10.4)
Gender
Male 16 780 (52.5) 93 902 (49.1)
Female 15 160 (47.5) 97 327 (50.9)
Self-assigned ethnicity (full breakdown)†
British 14 833 (50.5) 83 425 (55.6)
Irish 614 (2.1) 3819 (2.5)
Any other white background 2196 (7.5) 13 072 (8.7)
Mixed: white and black 770 (2.6) 2899 (1.9)
Mixed: white and Asian 104 (0.4) 421 (0.3)
Mixed: any other mixed background 277 (0.9) 961 (0.6)
Indian 413 (1.4) 2072 (1.4)
Pakistani 211 (0.7) 958 (0.6)
Bangladeshi 115 (0.4) 631 (0.4)
Any other Asian background 596 (2.0) 3105 (2.1)
Caribbean 2192 (7.5) 7654 (5.1)
African 2156 (7.3) 9178 (6.1)
Any other black background 2923 (10) 10 628 (7.1)
Chinese 107 (0.4) 593 (0.4)
Any other ethnic group 1865 (6.3) 10 715 (7.1)
Ethnicity not known or not stated 2589 (8.8) 41 132 (21.5)
Self-assigned ethnicity (amalgamated)†
British, Irish or any other white ethnic groups 17 643 (60.1) 100 316 (52.4)
Mixed 1151 (3.9) 4281 (2.2)
Indian, Pakistani, Bangladeshi or ‘other Asian’ 1335 (4.5) 6766 (3.5)
Caribbean, African or any ‘other black’ 7271 (24.8) 27 460 (14.4)
Other 1972 (6.7) 11 308 (5.9)
Area of most recently recorded residence‡
Croydon 6127 (19.5) 36 996 (20.4)
Lambeth 7043 (22.4) 33 471 (18.5)
Lewisham 5610 (17.8) 35 206 (19.4)
Southwark 6120 (19.4) 32 961 (18.2)
Other London boroughs 3179 (10.1) 27 012 (14.9)
Outside London 3395 (10.8) 15 649 (8.6)
Unknown 487 (1.5) 9968 (5.2)
Most recent employment status
Paid employment 439 (6) 5118 (13.4)
Part-time employment 114 (1.6) 581 (1.5)
Self-employed 31 (0.4) 408 (1.1)
Volunteer 67 (0.9) 95 (0.2)
Government training scheme <10 (0.1) 24 (0.1)
Full-time student 204 (2.8) 1623 (4.2)
Full-time student—school age 930 (12.7) 7725 (20.2)
Retired 504 (6.9) 6790 (17.8)
Registered disabled 71 (1.0) 352 (0.9)
Continued
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demonstrated, a group with and life expectancies at
birth reduced by 17–19 years compared with the general
population in England and Wales.47 48 Mortality out-
comes have been further evaluated in studies of cogni-
tive impairment and delirium in older adults.34 49
Studies of pharmacotherapy profiles have continued
investigations into mortality as an outcome, most notably
in a report identifying a marked reduction in people
using clozapine, not explained by a range of potential
confounders including service use.32 Another study
found that atypical antipsychotic agents were not asso-
ciated with higher mortality in people with vascular
dementia.33 Further work will examine antipsychotic
polypharmacy in more detail, following recent successful
development of algorithms to capture this.24 As
described earlier, utilising the keyword search function-
ality in CRIS, exposure to non-pharmacological agents
such as khat was investigated,14 and a large series of
cases with suspected neuroleptic malignant syndrome
were successfully identified which allowed a matched
case–control study of antipsychotic exposures potentially
responsible.12 13 The association between antidepressant
use and risk of mania and bipolar disorder has also
recently been investigated,50 as has antipsychotic use in
children and adolescents with autistic spectrum dis-
order.51 Finally, the potential to use extensive routine
data to monitor treatment response was exemplified in a
recent study of people receiving acetylcholinesterase
inhibitor treatments for Alzheimer’s disease in which tra-
jectories of cognitive function were plotted before and
after treatment initiation in order to identify predictors
of ‘response’—to our knowledge, the largest and most
extensive cohort of its kind.17
Recent developments which are likely to generate sub-
stantial future output include the assembly of one of the
largest cohorts to date of women with severe mental dis-
order who are followed from preconception and preg-
nancy to investigate medication use in relation to
maternal and fetal outcomes.52 Supplementing
CRIS-derived outcomes to large clinical research
samples with genetic profiling has also begun to gener-
ate novel output, for example, indicating that a well-
recognised genetic risk factor for schizophrenia may
also be a risk factor for worse clinical outcomes after
diagnosis.53 NLP applications have recently been
extended to cover a range of affective and psychotic
symptoms, allowing much more detailed phenotyping of
large samples than a diagnosis alone provides,54 55 and a
range of adverse drug events have also recently been
successfully captured.56
Table 2 Continued
Active patients (%) Inactive patients* (%)
Characteristic N=31 961 N=191 263
Unemployed 4827 (66.1) 14 949 (39.1)
Other 115 (1.6) 534 (1.4)
Employment status not known 24 654 (77.1) 153 064 (80.0)
Most recent marital status
Married 1329 (4.7) 13 701 (10.4)
Married/civil partner 3111 (11) 11 027 (8.3)
Cohabiting 556 (2.0) 2532 (1.9)
Divorced 622 (2.2) 3920 (3.0)
Divorced/civil partnership dissolved 633 (2.2) 2293 (1.7)
Separated 853 (3.0) 5303 (4.0)
Widowed 320 (1.1) 5985 (4.5)
Widowed/surviving civil partner 1046 (3.7) 4280 (3.2)
Single 19 763 (70) 83 319 (62.9)
Marital status not known or not disclosed 3728 (11.7) 58 903 (30.8)
*Inactive: those not currently receiving treatment and who have been discharged from all services.
†Excluding those not stated or none: active=2589/31961, inactive=41 132.
‡As at 31 December 2014.
Table 3 Characteristics of active and inactive cases on
the South London and Maudsley National Health Service
(NHS) Foundation Trust Biomedical Research Centre
(SLaM BRC) Case Register: most recent specialty (census
date: 31 December 2014)*
Current or most recent
SLaM specialty service
providing care
Number (%)
Active
patients
Inactive
patients†
Psychosis 7116 (22.3) 12 444 (6.5)
Child and Adolescent Mental
Health Services
5765 (18.0) 27 231 (14.2)
Mood, Anxiety and
Personality
5271 (16.5) 31 887 (16.7)
Mental Health of Older
Adults and Dementia
4217 (13.2) 24 842 (13.0)
Psychological Medicine 4333 (13.6) 59 212 (31.0)
Addictions 2559 (8.0) 12 768 (6.7)
Behavioural and
Developmental Psychiatry
3532 (11.1) 7898 (4.1)
Unknown/not recorded 719 (2.2) 80 440 (42.1)
*Some patients may have records with more than one specialty.
†Inactive: those not currently receiving treatment and who have
been discharged from all services.
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DISCUSSION
Currently, the SLaM BRC Case Register contains over
250 000 patient records and we believe it is the largest
mental health data resource of its kind (ie, derived from
the full EHRs for mental healthcare services). Since its
original description, the database has nearly doubled in
numbers of patients represented, but more importantly
there have been key developments in the infrastructure
to expand further the scale and depth of information
available for research.7 These developments have been
primarily in NLP and linkage with external data sets.
Strengths and limitations of NLP
NLP is being applied increasingly to extract information
from medical records, including applications for the
detection of specific adverse drug events and
other health events such as falls and nosocomial
infections,57–59 as well as use to identify obesity status
and obesity-related diseases.60 61 Furthermore, mining
patient electronic medical records has been found to be
useful for detecting patterns in patient care and patient
treatment habits.62 63 Statistical text mining has been
used to determine if patients suffer from comorbidities
Table 4 Characteristics of active and inactive cases on the South London and Maudsley National Health Service (NHS)
Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: patterns of multispecialty care (census date: 31
December 2014)
Number of specialties involved (current or most recent status)
Active patients Inactive patients
Specialty 1 2* 3+* 1 2* 3* 4* 5+*
Addictions 2349 197 13 9348 2181 903 315 21
Behavioural and Developmental Psychiatry 3347 178 <10 6484 962 324 114 14
Child and Adolescent Mental Health Services 5671 86 <10 24 299 2275 521 128 <10
Mental Health of Older Adults and Dementia 4173 42 <10 22 360 2159 261 55 <10
Mood, Anxiety and Personality 4653 582 36 19 595 8670 3105 493 24
Psychological Medicine 3818 481 34 40 778 14 199 3690 521 24
Psychosis 6509 580 27 4644 4522 2773 482 23
Total 30 520 1073 41 127 508 17 484 3859 527 24
*Include multiple counts of patients.
Table 5 Characteristics of active and inactive cases on the SLaM BRC Case Register: primary diagnoses ever recorded
(census date: 31 December 2014)*
Number (%)
Assigned primary diagnosis (ICD-10 code and description)
Active
patients
Inactive
patients†
F0–F09—organic, including symptomatic, mental disorders 3517 (11.0) 19 535 (10.2)
F10–F19—mental and behavioural disorders due to psychoactive substance use 3742 (11.7) 19 204 (10.0)
F20–F29—schizophrenia, schizotypal and delusional disorders 6778 (21.2) 10 069 (5.3)
F30–F39—mood (affective) disorders 6076 (19.0) 31 119 (16.3)
F40–F48—neurotic, stress-related and somatoform disorders 4155 (13.0) 22 800 (11.9)
F50–F59—behavioural syndromes associated with physiological disturbances and
physical factors
1025 (3.2) 5800 (3.0)
F60–F69—disorders of adult personality and behaviour 1518 (4.7) 4078 (2.1)
F70–F79—mental retardation 807 (2.5) 2050 (1.1)
F80–F89—disorders of psychological development 1483 (4.6) 4405 (2.3)
F90–F98—behavioural and emotional disorders with onset usually occurring in
childhood and adolescence
3607 (11.3) 10 343 (5.4)
Unspecified mental disorder 7016 (22.0) 28 122 (14.7)
No axis 1 diagnosis 526 (1.6) 6399 (3.3)
G—diseases of the nervous system 173 (0.5) 543 (0.3)
Other illness codes (A–E, H–Q) 669 (2.1) 7292 (3.8)
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 101 (0.3) 1164 (0.6)
S–Y—injury, poisoning and external causes 398 (1.2) 1416 (0.7)
Z—factors influencing health status and contact with health services 6384 (20.0) 42 552 (22.2)
Number of patients with a primary diagnosis recorded (% of all patients) 29 820 (93.3) 157 027 (82.1)
*Some patients may have had more than one primary diagnosis recorded.
†Inactive: those not currently receiving treatment and who have been discharged from all services.
ICD, International Classification of Diseases; SLaM BRC, South London and Maudsley National Health Service (NHS) Foundation Trust
Biomedical Research Centre.
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related to smoking, as well as detecting fall-related injur-
ies, and regular expressions have been used to extract
blood pressure values from progress notes.64–66 NLP has
been useful for extracting medical information such as
principal diagnosis, information related to employment
and medication use from clinical narratives.64 67 68 This
has led to a better understanding of the conditions
patients face and potential interventions.69 Manual chart
review for annotation has been used extensively and
when appropriate rigour is applied, the information
extracted is very reliable and is often used as the refer-
ence standard to evaluate IE systems. Although the
potential of NLP in mental health research was recog-
nised in 1992, there have been few applications in clin-
ical records from this specialty beyond those used for
de-identification purposes.70 However, progress is being
made, including US studies using NLP to determine
depression outcome, and adverse drug reactions, and
characterisation of diagnostic profiles.71–73
Considering performances of NLP IE applications
applied to clinical text, one study developed an NLP
system for classifying patients with 15 comorbidity states
for diseases related to obesity, found that the automated
system performed well against manual expert rule-based
systems, and concluded that even a relatively complex
task was possible for an automated system on the basis of
F-measures ranging from 0.48 for gastro-oesophageal
reflux disease as a comorbidity to 0.96 for depression,
and an overall system F-value of 0.60.74 Another study
evaluated automatic ascertainment of smoking status in
502 de-identified medical discharge records with 11
groups producing annotations and F-measures varying
from 0.33 to 0.70 for current smoking status and 0.44 to
0.76 for past smoking.75 F-measures for our applications
were therefore relatively favourable. On the other hand,
an application to identify and extract a patient’s
smoking status from clinical narrative text from Spanish
outpatient records, evaluated against manual annota-
tions, cited precision and recall statistics for a smoker
versus non-smoker classification of 85% and 90%,
respectively, and those for a current versus past smoker
classification as 91% and 94%.76 In our application, we
achieved comparable precision but lower recall.31
Preliminary studies ascertaining postoperative compli-
cations using NLP have been cited as yielding encour-
aging results.77 78 For example, in a recently conducted
pilot study of statistical NLP for identifying cases of deep
vein thrombosis (DVT) and pulmonary embolism (PE)
from free-text electronic narrative radiology reports, the
positive predictive value and sensitivity for DVT were
89% and 80%, respectively, and those for PE were 84%
and 79%.79 Another NLP application developed to
ascertain weekly warfarin doses reported findings of
Table 6 Number of patients represented on the SLaM
BRC Case Register with CRIS data linked to other data
sets
Data linkage
Number of patients on
both databases (% of
all CRIS active and
inactive patients)
CRIS* and ONS mortality† data 20 864 (9.3)
CRIS* and HES‡ data 188 447 (84.4)
CRIS* and cancer registry§ data 3442 (1.5)
*CRIS active and inactive patients recorded as at 31 December
2014.
†(Up to 16 of December 2013.)
‡Up to 31 March 2013.
§(Cancer registry data last updated 31 December 2008).
CRIS, Clinical Record Interactive Search; HES, Health Episode
Statistics; ONS, Office for National Statistics; SLaM BRC, South
London and Maudsley National Health Service (NHS) Foundation
Trust Biomedical Research Centre.
Table 7 Number of people represented on the SLaM
BRC Case Register with linked HES data
CRIS data*
HES data† Active (%) Inactive (%)
Any inpatient care‡ 18 387 (57.5) 137 577 (71.9)
Any emergency room
attendance‡
18 139 (56.8) 129 041 (67.5)
Any outpatient
attendance‡
20 642 (64.6) 150 748 (78.8)
*CRIS active and inactive patients recorded as at 31 December
2014.
†Excluding mental health inpatient/outpatient services.
‡Excluding mental health providers.
CRIS, Clinical Record Interactive Search; HES, Health Episode
Statistics; SLaM BRC, South London and Maudsley National
Health Service (NHS) Foundation Trust Biomedical Research
Centre.
Table 8 Number of people represented on the SLaM
BRC Case Register with linked HES and mortality data
Data linkage sample
Number of deaths (%)
Total
Linked to
ONS mortality
records*
People in CRIS† with at
least one inpatient
admission in HES
20 541 (9.2) 19 910 (8.9)
People in CRIS† with at
least one A&E attendance
record in HES
14 791 (6.6) 14 279 (6.4)
People in CRIS† with at
least one outpatient record
in HES
19 220 (8.6) 18 613 (8.3)
*Up to 16 of December 2013.
†All CRIS active and inactive patient deaths recorded up to 16
December 2013.
A&E, accident and emergency; CRIS, Clinical Record Interactive
Search; HES, Health Episode Statistics; ONS, Office for National
Statistics; SLaM BRC, South London and Maudsley National
Health Service (NHS) Foundation Trust Biomedical Research
Centre.
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90.8% precision and 99.7% recall, and a broader
medication-ascertaining application achieved 86% preci-
sion and 77% recall.68 80 In our own data, an evaluation
of the NLP diagnosis application yielded a precision of
99% and a recall of 98% for vascular dementia, and our
evaluations of the pharmacotherapy application found
over 90% precision and recall for clozapine, although
higher accuracy may be due to the combined use of
structured data. It should be borne in mind that perfor-
mances for one diagnosis or medication cannot be
assumed to generalise to others, so it is still CRIS policy
to advise de novo evaluation of application performance
in studies investigating previously unevaluated entities.
This is particularly pertinent to investigating anti-
psychotic medication prescribing, which is frequently
preceded by clinical discussions and possibly tests (ie,
clozapine); therefore, the presence of multiple annota-
tions may not be reflective of current prescribing.
As displayed in table 12, the development of NLP IE
applications to date has resulted in a very substantial
expansion in data fields available for analysis within the
SLaM BRC Case Register and in the ability to construct
longitudinal data sets with repeated measures (as illu-
strated for MMSE score trajectories before and after ini-
tiation of dementia treatment).17 With increasing use of
EHRs, we believe that NLP techniques have an import-
ant role to play, whether derived metadata are to be
used for research or to enhance the quality of the clin-
ical record. This is particularly pertinent for mental
health records where text fields are often substantial
and contain some of the most important clinical infor-
mation. However, although its potential is substantial, it
is important to bear in mind that there may be limits in
the usefulness of NLP in EHR-sourced data resources,
because of the high degree of variability in clinical text.
As well as the well-recognised challenges of non-
grammatical sentences, misspellings, idiosyncratic abbre-
viations and jargon, there are more complex issues to
deal with such as the establishment of temporality (eg,
timing of events described in long case summaries), the
classification of documents and within-document text
domains (eg, sections of the history or mental state
assessment), and the development of standard
Table 9 Number of deaths in SLaM linked with ONS
mortality data by underlying primary cause of death (latest
date of record is as at 16 of December 2013)
ICD-10 chapter description
(underlying cause of death)
Number of patients
(% of all deaths in
CRIS) (N=20 864)
Benign neoplasms or diseases of
the blood
159 (0.8)
Cancers 3356 (16.1)
Certain conditions originating in the
perinatal period and pregnancy,
childbirth and the puerperium
<10
Codes for special purposes
(eg, antibiotic resistance)
45 (0.2)
Congenital malformations,
deformations and chromosomal
abnormalities
73 (0.3)
Diseases of the circulatory system 5665 (27.2)
Diseases of the digestive system 1467 (7)
Diseases of the genitourinary
system
689 (3.3)
Diseases of the musculoskeletal
system
241 (1.2)
Diseases of the nervous system 1338 (6.4)
Diseases of the respiratory system 2964 (14.2)
Diseases of the skin 80 (0.4)
Endocrine, nutritional and metabolic
diseases
445 (2.1)
External causes 1294 (6.2)
Infectious and parasitic diseases 356 (1.7)
Mental and behavioural disorders 2206 (10.6)
Symptoms and sign not elsewhere
classified
376 (1.8)
Unknown/ missing 102 (0.5)
CRIS, Clinical Record Interactive Search; ICD, International
Classification of Diseases; ONS, Office for National Statistics;
SLaM, South London and Maudsley.
Table 10 Numbers of patients with both CRIS and
cancer registry data, by primary cancer diagnosis (linkage
last updated 31 December 2008)
Primary diagnosis
(ICD-10 3-digit description)
Number (%)
of patients
Malignant neoplasm of breast 563 (16.4)
Carcinoma in situ of cervix uteri 394 (11.4)
Malignant neoplasm of prostate 391 (11.4)
Malignant neoplasm of bronchus and lung 306 (8.9)
Malignant neoplasm of colon 179 (5.2)
Other malignant neoplasms of skin 152 (4.4)
Malignant neoplasm of bladder 92 (2.7)
Malignant neoplasm of rectum 90 (2.6)
Malignant neoplasm of corpus uteri 71 (2.1)
Malignant neoplasm of kidney, except
renal pelvis
70 (2.0)
Other and unspecified types of
non-Hodgkin’s lymphoma
65 (1.9)
Malignant melanoma of skin 58 (1.7)
Malignant neoplasm of brain 57 (1.7)
Malignant neoplasm of pancreas 53 (1.5)
Malignant neoplasm of stomach 53 (1.5)
Malignant neoplasm without
specification of site
53 (1.5)
Malignant neoplasm of oesophagus 50 (1.5)
Malignant neoplasm of cervix uteri 48 (1.4)
Malignant neoplasm of ovary 46 (1.3)
Diffuse non-Hodgkin’s lymphoma 42 (1.2)
Myeloid leukaemia 42 (1.2)
Lymphoid leukaemia 39 (1.1)
Multiple myeloma and malignant plasma
cell neoplasms
36 (1.0)
Malignant neoplasm of larynx 34 (1.0)
Other diagnoses 458 (13.3)
CRIS, Clinical Record Interactive Search; ICD, International
Classification of Diseases.
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ontologies, not to mention the challenges of translation
and harmonisation across languages. An important deci-
sion in NLP application development at the outset is
whether near-perfect performance is required at an indi-
vidual level, or whether a lower performance probabilis-
tic approach might be appropriate. The latter may be
sufficient for analyses to be carried out over large
samples, but the former is likely to be required if the
application is then to be used for clinical decision
support.
Strengths and limitations of data linkages
As well as NLP applications, we were also able to expand
the depth of information in this mental health case regis-
ter through linkages with external data, including mor-
tality, cancer and hospitalisation, with a primary care
linkage recently developed and a linkage with education
records fully approved and about to be implemented.
Data linkage has been used in a variety of registers to
enhance research questions. For example, nationwide
data from the Icelandic Medicines Registry and the
Database of National Scholastic Examinations were
linked to study associations between drug treatment of
attention deficit/hyperactivity disorder and academic
performance.81 In Sweden, acute myocardial infarction
episodes were linked with routinely collected data on
hospital discharges, mental health and mortality.82 UK
general practice data have been linked to national mor-
tality, hospitalisation and disease register data at an indi-
vidual level, and to census-derived socioeconomic data at
a small area level.83 The Western Australian e-cohort of
half a million children included data cross-linked across
a number of administrative registers including education,
mental healthcare, hospital discharges, midwives notifi-
cations, cancer registrations, a registry of births, deaths
and marriages and emergency presentations.4
Techniques for achieving both valid and secure data
linkages within a robust governance framework are
becoming increasingly standardised. In the Western
Australian system, in order to protect privacy, linkage
and analysis tasks are performed separately and linked
data sets have identifiers removed before they are made
available to researchers. Comparable procedures are fol-
lowed in CRIS linkages. The data linkage process in
Western Australia involves probabilistic methods to calcu-
late the likelihood that two records belong to the same
entity (person, family, event and location), whereas an
important feature of the UK NHS is the NHS number, a
unique reference for all patients, which we were able to
use as the primary link for health-related information
with CRIS data. Unique identifiers assigned at birth also
exist in a number of other countries, including the
unique citizen identifier, Civil Personal Registration
number in Denmark covering prescription drug
Table 11 Performance of natural language processing information extraction applications developed to date in the SLaM
BRC Case Register
Application name Construct sought
Number of patients
tested Precision Recall F-statistic
Smoking31 Is the patient a current smoker? 100 0.93 0.58 0.72
Clozapine—current
use32
Is the patient currently using clozapine (within
3 months)?
Precision: 279,
recall: 200
0.96 0.92 0.94
Clozapine—ever
used32
Has the patient used clozapine in the past? Precision: 279,
recall: 200
0.99 0.92 0.95
Diagnosis33 What text accompanies a statement about
diagnosis?
75 0.99 0.98 0.99
MMSE34 What MMSE score did the patient attain on a
given date?
100 0.97 0.98 0.97
Education What age did a patient leave school? Precision: 100,
recall: 115
0.95 0.59 0.73
Living alone Is the patient living alone? 100 0.93 0.99 0.96
Amisulpride24 Is the patient currently using amisulpride? 20 patients with 619
instances
0.97 0.61 0.75
Flupentixol24 Is the patient currently using flupentixol? 20 patients with 328
instances
0.94 0.77 0.85
Haloperidol24 Is the patient currently using haloperidol? 20 patients with 747
instances
0.94 0.57 0.71
Olanzapine24 Is the patient currently using olanzapine? 20 patients with 1150
instances
0.95 0.69 0.80
Risperidone24 Is the patient currently using risperidone? 20 patients with 737
instances
0.95 0.64 0.76
Zuclopenthixol24 Is the patient currently using zuclopenthixol? 20 patients with 390
instances
0.97 0.68 0.80
MMSE, Mini-Mental State Examination; SLaM BRC, South London and Maudsley National Health Service (NHS) Foundation Trust Biomedical
Research Centre.
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purchases, hospital inpatient, emergency and outpatient
encounters, admissions to psychiatric hospitals, a range
of disease-specific registries, primary care data and cause
of death.84 In Taiwan, social insurance enumeration
systems have been used to create the National Health
Insurance Research Database which has high national
coverage and includes data from social insurance, health
information, census and education resources.85
Record linkages are particularly valuable when they
enable the capture of exposure data from one source
and outcome data from another source, and have
enabled novel investigations such as those attained
through linking conscription surveys in Sweden and
Israel with healthcare registers. Databases utilising the
northern European system of unique citizen number
will still have particular value in the following respects:
(1) where information is gained on the total population
within a geographic or administrative area, and not only
insured patients; (2) where the person identifier is used
for wider purposes than healthcare allowing novel and
informative linkages, as discussed. The development of
these linkages for the SLaM BRC Case Register is thus
comparable with current practice elsewhere; however,
the depth of information on mental healthcare accessed
by CRIS is, we believe, currently unique in scale and
scope, which we hope will enable findings from larger
national samples to be further investigated in greater
depth at a local level. There are various limitations with
data linkage. First of all, most of the data linked to CRIS
have time limitations, and cannot be used to develop
decision support applications, because they are not avail-
able in real time. Mismatched identifier variables also
place limits on the linkage process, although we have
found this to be rare for the NHS number.
Collaborations
Work to date on the SLaM BRC Case Register has
involved a number of welcomed collaborations, includ-
ing those with other academic groups, both national and
international, as well as with industry partners in
pharmaceutical and biotech sectors. The authors par-
ticularly acknowledge the longstanding and fruitful col-
laboration with the University of Sheffield Department
of Computer Science on the application of NLP techni-
ques. The primary consideration with collaboration is
the requirement (a component of the Case Register’s
ethics approval) that all data remain within the NHS
firewall during analysis. In order to facilitate this, a dedi-
cated office suite was set up in SLaM premises, the ‘BRC
Nucleus’ to accommodate staff and visitors accessing
Case Register data, although remote access, with appro-
priate security, is also possible. A second requirement is
an appropriate affiliation with SLaM for those accessing
the data, most usually taking the form of an honorary or
substantive contract, or a ‘research passport’, but also
covered on occasions by appropriate between-institution
legal agreements as directed by the SLaM Caldicott
Guardian—the statutory office overseeing the use of
patient information in the NHS. All research projects
using CRIS are considered and approved by a patient-led
Oversight Committee, reporting to the Caldicott
Guardian, as described in detail elsewhere.8 As well as
considering the appropriateness of research proposals,
the CRIS Oversight Committee also adjudicate on risks
of de-anonymisation at the analysis planning stage and,
if needed, in the preparation of findings for publication
(eg, proof-reading papers reporting quoted text
excerpts).
Implications and challenges for future developments
Data derived from EHRs have huge potential to contrib-
ute to research and clinical care. Observational data are
vital in healthcare-relevant research. As well as research
into disease risk factors, incidence and prognosis, an
important application of EHR-derived data is in provid-
ing ‘real-world’ information on response to routine clin-
ical interventions (eg, recovery, adverse events) and,
most importantly, predictors of response. The
Table 12 Summary of number of annotations generated
from NLP applications in the SLaM BRC Case Register*
Application name
Total number
of instances
generated
Number of patients
with at least one
instance generated
MMSE 107 384 24 705
Diagnosis 615 237 78 851
Smoking 670 053 52 700
Education 181 905 51 665
Medication (selected)†
Olanzapine 371 754 25 697
Citalopram 144 072 24 363
Mirtazapine 135 309 23 710
Risperidone 240 068 22 046
Zopiclone 129 488 20 712
Diazepam 129 409 17 841
Lorazepam 119 357 15 637
Fluoxetine 96 258 15 527
Sertraline 95 381 13 600
Promethazine 112 256 12 861
Clonazepam 111 279 9679
Quetiapine 98 509 9503
Aripiprazole 90 866 8737
Haloperidol 53 936 7591
Amisulpride 58 751 6759
Methadone 128 132 6385
Flupentixol 25 576 5248
Clozapine 111 170 4364
Zuclopenthixol 18 099 3093
*The CRIS database is updated every 24 h, so numbers are
dynamic and displayed for illustrative purposes. NLP application
run dates as follows: MMSE (24 June 2014), diagnosis (20 June
2014), smoking (17 July 2014), education (30 June 2014),
medication (16 June 2014).
†Most frequent 15 agents plus those evaluated in table 11.
CRIS, Clinical Record Interactive Search; MMSE, Mini-Mental
State Examination; NLP, natural language processing; SLaM
BRC, South London and Maudsley National Health Service (NHS)
Foundation Trust Biomedical Research Centre.
18 Perera G, et al. BMJ Open 2016;6:e008721. doi:10.1136/bmjopen-2015-008721
Open Access
 o
n
 June 23, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2015-008721 on 1 March 2016. Downloaded from 
ascertainment of characteristics predicting good/poor
intervention response supports ‘personalised medicine’.
Compared with EHRs, randomised trials are insuffi-
ciently powered, even when combined, to detect predic-
tors of response, and their samples are frequently highly
selected—hence the need for large, generalisable data
sets containing detailed information on routine clinical
care. For example, the recently reported CRIS study of
MMSE score trajectories before and after acetylcholines-
terase inhibitor treatment initiation in dementia cap-
tured data on at least eight times more person-years of
treatment from a single mental healthcare provider than
all randomised controlled trial samples combined, as
well as providing the added generalisability of ‘real-
world’ data.17 EHR databases also potentially allow
enhanced and more effectively targeted recruitment for
randomised controlled trials and other intervention eva-
luations, in addition to permitting pretrial modelling
and efficiency planning. Approach for research study
participation is generally considered to require prior
consent (ie, ‘opt in’), and a ‘Consent for Contact’
model for patient recruitment has been developed at
SLaM.86
In the UK, EHRs are now near-ubiquitous in primary
care and mental healthcare, and rapidly becoming so
in acute care. However, realising their potential for clin-
ical research depends heavily on the quality and nature
of EHR data. In mental healthcare, applications have
been very limited to date. In particular, although nearly
all mental health services use EHRs, most clinically
relevant information (eg, on symptoms, interventions,
outcomes) is recorded in text and therefore not access-
ible for large-scale analyses to inform service planning,
or for algorithms to support clinical decision-making.
Given the very high individual and societal impact of
disorders such as schizophrenia, bipolar disorder,
depression and dementia, and the large mental health-
care sector, this data deficiency is a major limitation.
For example, current national data on mental health-
care in the UK are principally available from three
sources: (1) primary care data resources such as the
Clinical Practice Research Datalink which covers
approximately 5–10% of general practices;87 (2) HES;88
and (3) the Mental Health Minimum Data Set
(MHMDS). However, each has key limitations. Primary
care data do not contain information on mental health
service interventions or sufficient information on the
symptoms for which interventions are received and
with which outcomes are evaluated. HES data are pri-
marily used for identifying inpatient episodes and have
limited data on interventions or outcomes beyond
service receipt. The MHMDS covers mental healthcare
more comprehensively; however, data are essentially
restricted to service-level interventions (eg, pharmaco-
therapy is not recorded), and information on symptom-
atology and context for most patients is restricted to
the relatively coarse Health of the Nation Outcome
Scales.89
One solution for improving the structure of routine
clinical data in the EHR would be to impose this struc-
ture at the point of data entry. However, the applicability
of this approach depends on the willingness of clinical
staff to input structured data; the accuracy of form com-
pletion; and on the extent to which the disorders, inter-
ventions and outcomes can be captured in pre-prepared
scales. Our experience has been that imposition of struc-
tured fields in a clinical record is difficult to achieve,
and even more so to sustain, at least within mental
healthcare. Furthermore, although a structured field
improves data accessibility, it does not necessarily render
the data any more valid. Even in a clinical context where
data have inherent structure (eg, blood pressure record-
ings following hypertension treatment), this approach
has limitations and may fail to capture influential con-
textual factors (eg, suboptimal adherence to antihyper-
tensive treatment, or ‘white coat hypertension’).
Application of structure is particularly challenging in
mental healthcare where interventions are primarily
determined by qualitatively reported experiences (symp-
toms), where outcomes rely on tracking improvement or
deterioration of the same constructs, and where some
interventions themselves are not readily prestructured
(eg, psychotherapeutic strategies). Although constructs
such as medication sound amenable to imposed struc-
ture, this is limited in UK services because of the mixed
prescribing between primary and mental healthcare.
Structured recording of current medication outside a
prescribing database is difficult to maintain with any
accuracy because there is no clear gain for clinicians to
enter medication receipt in a structured field compared
with recording the same information in text. We have
demonstrated that it is feasible to obtain at least some
novel structured information from routine mental
health records on a range of clinical indicators using
NLP. The over-riding advantage of this approach is that
no additional ‘data entry’ is required by clinical staff
beyond what is normal practice. The validity of the
approach has been demonstrated in a typical mental
health service EHR at SLaM and it is reasonable to
suppose at least some generalisability to other UK
mental health services, given the relatively standardised
nature of clinical assessments and national training in
psychiatry. However, clearly cross-applicability is import-
ant to evaluate and in this respect it is advantageous that
the CRIS application was successfully implemented in
2014 at four other mental health Trusts with
comparable EHR systems (http://www.slam.nhs.uk/
research/d-cris). Finally, as with all data derived from
routine sources, it is important to bear in mind, when
designing investigations, the reasons why information
may or may not be recorded in clinical practice—includ-
ing the incentives for recording within different clinical
services or at different points on the healthcare pathway.
For example, in early analyses using the application to
ascertain current smoking status, it was found that
missing data were relatively high unless the focus was on
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patients who had received at least a year’s care from
SLaM.31 Enhancing the structure of a record could be
one answer, although better design and focusing of text
fields may in the end be more acceptable.
A more generic challenge for the use of specialist
healthcare data lies in the limited time ‘windows’ within
which data are provided. Cohort studies using such data
resources therefore need to take into account not only
what data are available from the record but also the
time periods within which they are available. These time
periods also need to be carefully considered in relation
to the question under investigation, since they are deter-
mined by discharge and/or re-referral, which clearly
themselves are determined by factors such as recovery,
engagement with services and out-migration from the
catchment. Those patients on whom longest periods of
follow-up are available are likely to be those who have
more severe symptomatology (requiring longer periods
of care), although they may also have more stable
accommodation or support and thus less likelihood of
out-migration. Data linkages can provide some means of
addressing the problem—for example, national data on
hospitalisation or mortality accrue regardless of a
patient’s contact or not with mental healthcare; however,
these may be limited in depth of information, as
described above.
A key challenge inherent with all use of healthcare
data is how to ensure such data are appropriately and
robustly protected and how to develop and to use anon-
ymised clinical information in a way that is acceptable to
the general public, and most importantly to patients.
Such challenges incorporate not only a case register’s
data themselves but also procedures around data linkage
where use of identifiers is required, although systems are
increasingly becoming established which achieve data
linkage in ways that effectively preserve anonymity. Data
protection laws and practice vary internationally, but
most do have some provision for the use of data without
prior consent if these data are effectively anonymised
and if important research cannot be carried out in any
other way. It is also worth bearing in mind at the outset
that few data sets can be claimed to be wholly anon-
ymised. For example, even in the shallowest of adminis-
trative databases, a combination of age, gender and
date/place of admission might well be sufficiently unique
that it theoretically identifies a person. Technical solu-
tions to anonymisation are therefore never sufficient on
their own, but need to be accompanied by a governance
structure which evaluates database use for any risk of
compromising anonymity, as well as monitoring the
appropriateness of the research being carried out, and of
the people and agencies having data access. The coming
years will bring many more opportunities for the use and
linking of anonymised EHR data. It is clear that research-
ers, patients and the general public need to be engaged
in ongoing conversations and collaborations to develop
appropriate frameworks so as to maximise the use of
such data in ways that maintain the trust of all parties.
The SLaM BRC Case Register involved patients from the
outset both in designing the security model and in
leading ongoing oversight of data use and dissemin-
ation,8 thus ensuring that discussions about the future of
EHR use (scientifically, and as a sociological question)
effectively and meaningfully engage the stakeholders
whose data have generated the resource in the first place.
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